Literature DB >> 10726054

Hepatitis delta virus: molecular biology, pathogenesis and immunology.

J L Casey1.   

Abstract

Hepatitis delta virus (HDV) is a unique infectious agent which causes severe liver disease in those infected with its helper virus, hepatitis B virus. No effective antiviral therapy for HDV exists. This review covers recent advances in the molecular biology, pathogenesis and immunology of HDV, with an emphasis on potential targets for the development of successful antiviral agents.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10726054

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


  2 in total

1.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.

Authors:  Camille Sureau; Chantal Fournier-Wirth; Patrick Maurel
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.